Janssen COVID-19 Vaccine (Johnson & Johnson)

Summary of Recent Changes and Updates

Webpage content and individual PDFs are updated when there’s new guidance concerning the Janssen (Johnson & Johnson) COVID-19 Vaccine. Expand each section below to see a summary of new and updated items.

General J&J/Janssen Vaccine Information
Administration Overview

Before administering vaccine, screen recipients for contraindications and precautions, even if the recipient is scheduled to receive the second or booster dose. The recipient’s health condition or recommendations regarding contraindications and precautions for vaccination may change from one visit to the next.

To assess patients correctly and consistently, vaccination providers should use a standardized, comprehensive screening tool.

Contraindications and Precautions
How to Prepare and Administer the Janssen Vaccine
Janssen COVID-19 Vaccine Administration Resources
Document the Vaccination

COVID-19 vaccination providers must document vaccine administration in their medical record systems within 24 hours of administration and use their best efforts to report administration data to the relevant system for the jurisdiction (i.e., immunization information system) as soon as practicable and no later than 72 hours after administration.

Storage and Handling Overview

Store vaccine in a refrigerator. Do not freeze.

The vaccine will arrive at a refrigerated temperature of 2°C to 8°C (36°F and 46°F).

  • Unpack the vaccine shipment following the manufacturer’s directions.
    • As a backup to the qualified shipping container, temperature monitors are placed in each shipment. Only warm monitors will be included in Janssen shipments.
    • Remove the instruction card for the temperature monitor immediately. Follow the guide on the back of the card to read the monitor.
  • An ancillary supply kit will arrive separately from the vaccine.
How to Store the Janssen COVID-19 Vaccine
Report Adverse Events

Adverse events that occur in a recipient after COVID-19 vaccination are required to be reported to the Vaccine Adverse Event Reporting System (VAERS). FDA requires vaccination providers to report vaccine administration errors, serious adverse events, cases of multisystem inflammatory syndrome, and cases of COVID-19 that result in hospitalization or death after administration of COVID-19 vaccine under an EUA. Reporting is encouraged for other clinically significant adverse events, even if it is not clear that a vaccine caused the adverse event. Complete and submit reports to VAERS online.

For further assistance with reporting to VAERS, call 1-800-822-7967.

What to Expect after a COVID-19 Vaccination

Print information for your patients on common side effects, helpful tips, and when to call a doctor after a COVID-19 vaccination.

email_03Get Email Updates

To receive email updates about this page, enter your email address:

Page last reviewed: April 27, 2022